Cgi Approval News Today

Despite the Drugs Controller General of India having functioned in a whimsical and opaque manner, the draft bill does not curb its vast discretionary powers.

Maharashtra based pharmaceutical company has the highest market share in low dose atropine -- MYATRO 0.01 per cent eye drops -- is used to treat eye problems like myopia, especially in children.

Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.

The Drug Controller General of India (DCGI) has given its nod to Molnupiravir for Emergency Use Authorisation (EUA) for the treatment of adult patients with Covid-19 and who have high risk of progression of the disease.

According to the data shared by the Union Health Ministry on Friday, the country saw a total of 35,743 discharges in the last 24 hours.

Cyrus poonawalla, covishiled, covaxin, covid vaccines, bharat biotech, serum institute of india, adar poonawalla, serum institute chairman, covid vaccination, vaccine doses covid 19, coronavirus vaccination, icmr report, dcgi approval, mixing covid vaccines, daily covid caseload, covid cases today

Zydus Cadila has concluded its clinical trials for the 12 to 18 age group, and the vaccine may be available in near future, subject to the statutory permissions.